Jun 2025 $11 M Private placement after listing $10 to $50 million 5
Biofrontera Inc.: Private sale, Jun 2025 × Investors in this round 5 investors had bought by the notice of Jul 11, 2025: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $11 M of $11 M offered
Smallest investment taken no minimum stated
What was sold equity, other: Series C Convertible Preferred Stock Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Eugene Frederick Leffler, III · Executive Officer Hermann Luebbert · Executive Officer, Director Beth J. Hoffman · Director Heikki J. Lanckriet · Director John J. Borer III · Director Kevin D. Weber · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “The issuer agreed to sell up to 11,000 shares of its Series C Convertible Preferred Stock & issue such shares in two tranches of 8,500 shares & 2,500 shares, respectively, as disclosed in a Current Report on Form 8-K filed with the SEC on July 1, 2025.”On a merger: “The funds raised in the offering will be used, at least in part, to pay costs related to the acquisition of all U.S. assets related to certain products & associated patents as disclosed in a Current Report on Form 8-K filed with the SEC on June 30, 2025.”Signed by E. Fred Leffler, III, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 11, 2025. Read the notice at the SEC .
equity SEC Feb 2024 $8 M Private placement after listing $2 to $10 million 8
Biofrontera Inc.: Private sale, Feb 2024 × Investors in this round 8 investors had bought by the notice of Mar 5, 2024: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $8 M of $8 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $685,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Eugene Frederick Leffler, III · Executive Officer Hermann Luebbert · Executive Officer, Director Beth J. Hoffman · Director Heikki J. Lanckriet · Director John J. Borer III · Director Kevin D. Weber · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Roth Capital Partners, LLC (CRD 15407) · Newport Beach, California Sold in MD, NV, NY, and outside the US Remarks in the notice On the amounts: “The Company sold approximately 6,586 shares of Series B-1 Convertible Preferred Stock and warrants to purchase shares of Series B-3 Convertible Preferred Stock as first disclosed on its Current Report on Form 8-K filed with the SEC on February 20, 2024.”Signed by E. Fred Leffler, III, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 5, 2024. Read the notice at the SEC .
equity, options SEC Oct 2022 $4 M Private placement after listing $2 to $10 million 1
Biofrontera Inc.: Private sale, Oct 2022 × Investors in this round 1 investor had bought by the notice of Nov 4, 2022: 0 accredited, 1 not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Erica F Gates · Executive Officer · Senior Director Finance of Biofrontera Inc. Erica L Monaco · Executive Officer · Chief Executive Officer of Biofrontera Inc. Eugene Frederick Leffler · Executive Officer · Chief Financial Officer of Biofrontera Inc. Hermann J Luebbert · Executive Officer, Director · Executive Chairman and Director of Biofrontera Inc. Beth J Hoffman · Director John J III Borer · Director Kevin D Weber · Director Loretta M Wedge · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Reflects a privately negotiated exchange of 3,148,042 shares of Biofrontera Inc. common stock for an option to acquire 2,623,365 shares of Biofrontera AG. Offering amount based upon closing price of Biofrontera Inc. on 10/25/2022 ($1.17).”Signed by Erica Monaco, Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 4, 2022. Read the notice at the SEC .
equity SEC Jul 2022 $7 M Private placement after listing $2 to $10 million 1
Biofrontera Inc.: Private sale, Jul 2022 × Investors in this round 1 investor had bought by the notice of Aug 11, 2022: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $7 M of $7 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Erica F Gates · Executive Officer Erica L Monaco · Executive Officer Hermann J Luebbert · Executive Officer, Director Beth J Hoffman · Director John J III Borer · Director Kevin D Weber · Director Loretta M Wedge · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Total offering amount and total amount sold includes warrants to purchase 4,285,715 shares of common stock. See the Company's Form 8-K filed with the SEC on July 28, 2022 regarding the transaction.”Signed by Erica Monaco, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 11, 2022. Read the notice at the SEC .
equity, options SEC May 2022 $9 M Private placement after listing $2 to $10 million 1
Biofrontera Inc.: Private sale, May 2022 × Investors in this round 1 investor had bought by the notice of May 23, 2022: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $9 M of $9 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $660,123
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Erica F Gates · Executive Officer Erica L Monaco · Executive Officer Hermann J Luebbert · Executive Officer, Director Beth J Hoffman · Director John J III Borer · Director Kevin D Weber · Director Loretta M Wedge · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round The Benchmark Company, LLC (CRD 22982) · New York, New York Sold in NY Roth Capital Partners, LLC (CRD 15407) · Newport Beach, California Sold in NY Signed by Erica Monaco, Chief Executive Officer. Source: SEC Form D, newest notice filed May 23, 2022. Read the notice at the SEC .
equity, options SEC Nov 2021 $15 M No. 1 $10 to $50 million 1
Biofrontera Inc.: Raise no. 1, Nov 2021 × Investors in this round 1 investor had bought by the notice of Dec 10, 2021: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $15 M of $15 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $1,198,794
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Erica F Gates · Executive Officer Erica L Monaco · Executive Officer Hermann J Luebbert · Executive Officer, Director Beth J Hoffman · Director John J III Borer · Director Loretta M Wedge · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Roth Capital Partners, LLC (CRD 15407) · Newport Beach, California Sold in NY The Benchmark Company, LLC (CRD 22982) · New York, New York Sold in NY Signed by Erica Monaco, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 10, 2021. Read the notice at the SEC .
equity, options SEC